Search Thermo Fisher Scientific
- Order Status
- Quick Order
-
Don't have an account ? Create Account
Search Thermo Fisher Scientific
Make your workplace safer with the MicroScreen 2 and Microscreen Split urine drug and alcohol screening cups. Designed for use across a diverse range of industries such as mining, transportation, manufacturing, healthcare, construction, agriculture and marine operations. MicroScreen 2 and MicroScreen Split cups help quickly identify risks and support the prevention of workplace injuries caused by the use of illicit drugs, alcohol and dangerous substances.
Informational: This product is not available for purchase by the general public
The MicroScreen™ 2 urine drug testing cup provides preliminary screening for six drugs of abuse:
The MicroScreen 2 is independently validated (AS/NZS4308:2008) for workplace and forensic use as well as for clinical use. ARTG (Ref: 370490)
The MicroScreen™ 2 Plus urine drug and alcohol screening cup provides preliminary testing for eight drugs of abuse:
The MicroScreen 2 Plus is independently validated (AS/NZS4308:2008) for workplace testing and forensic use only
The MicroScreen Split urine drug testing cup provides preliminary screening for six drugs of abuse:
The MicroScreen Split Cup is independently validated (AS/NZS4308:2008) for workplace and forensic use only
Tilt Cup Drug Testing Cup |
Split Cup Drug Testing Cup |
|
---|---|---|
Tamper proof design | Separate test lid and cup. Unlike all-in-one devices, the donor does not handle the testing panel component of the MicroScreen 2 device, significantly reducing the potential risk for tampering. | Protective label hides the test panel and adulteration strips from the donor. |
Test activation | Elegant tilt design that’s easy for collectors to control when the test starts. | Key activated. Test starts when the collector is ready (not when the subject gives the specimen) and is activated with a simple key mechanism. |
Lid | Tamper proof secure screw lid provided in separate packaging. | Robust no-leak rubber seal with a click-down lid. |
Simplicity and user-friendly | Compact box with a smaller footprint than other cups in the market allowing for easy transportation and storage. Rapid results with minimal urine required. (Results ready in 5-10 minutes) |
Rapid results with minimal urine required. (Results ready in 5-10 minutes) 3-step process: Collect urine, push the key and read the results. |
Validation | Independently validated (AS/NZS4308:2008) for workplace and forensic use. The MicroScreen2 Cup is also included on the ARTG (Ref: 370490) for clinical use. | Independently validated (AS/NZS4308:2008) for workplace and forensic use. |
Step 1: Client receives MicroScreen 2 cup component and collects sample
Step 2: Record temperature and verify it is within range (32 - 38℃)
Step 3: Attach the test panel lid to the cup with the collected sample, ensuring correct alignment to prevent cross-threading and leakage
Step 4: Tilt to run. Place cup on its side and read results after 5 minutes
A negative test is indicated by the presence of a test line below each designated drug. Note: Line intensities will vary. Any line, even faint, = NEG.
The ABSENCE of a test line (T) for a designated drug = POS.
An invalid test is indicated when the control lines (C) are completely missing in one or more of the test windows. In the event of an invalid screen, a second screen should be performed.
Step 1: Client receives MicroScreen Split cup and collects sample. Collector records the temperature and verify it is within range (32 - 38℃)
Step 2: Place cup on a flat surface, insert key and push in
Step 3: Peel off the label to view results.
Interpret adulteration strips between 3-5 minutes. Refer to enclosed colour chart for interpretation. Do not read results past 10 minutes
Drug test | GC-MS (<-50% C/0) |
GC-MS (-50% C/0 to C/0) |
GC-MS (C/0 to +50% C/0) |
GC-MS (>+50% C/0) |
% Agreement with GC/MS |
|
AMP/300 | (+) | 0 | 1 | 11 | 52 | 100% |
(-) | 40 | 9 | 0 | 0 | 98% | |
BZO/200 | (+) | 0 | 3 | 13 | 43 | 100% |
(-) | 40 | 10 | 0 | 0 | 94.30% | |
COC/300 | (+) | 0 | 0 | 10 | 35 | 100% |
(-) | 40 | 12 | 0 | 0 | 100% | |
ETG/500 | (+) | 0 | 1 | 15 | 65 | 97.65% |
(-) | 141 | 23 | 5 | 0 | 99.40% | |
MET/300 | (+) | 0 | 0 | 9 | 43 | 98.10% |
(-) | 40 | 7 | 1 | 0 | 100% | |
OPI/300 | (+) | 0 | 1 | 10 | 46 | 100% |
(-) | 40 | 8 | 0 | 0 | 98% | |
OXY/100 | (+) | 0 | 3 | 7 | 33 | 100% |
(-) | 40 | 1 | 0 | 0 | 93.20% | |
THC/50 | (+) | 0 | 1 | 11 | 44 | 100% |
(-) | 40 | 7 | 0 | 0 | 97.90% |
AMP | (ng/ml) | 0 | 150 | 450 |
(+/-) | 0/30 | 0/30 | 30/0 | |
BZO | (ng/ml) | 0 | 100 | 300 |
(+/-) | 0/30 | 0/30 | 30/0 | |
COC | (ng/ml) | 0 | 150 | 450 |
(+/-) | 0/30 | 0/30 | 30/0 | |
EtG | (ng/ml) | 0 | 250 | 750 |
(+/-) | 0/30 | 0/30 | 30/0 | |
MET | (ng/ml) | 0 | 150 | 450 |
(+/-) | 0/30 | 0/30 | 30/0 | |
OPI | (ng/ml) | 0 | 150 | 450 |
(+/-) | 0/30 | 0/30 | 30/0 | |
OXY | (ng/ml) | 0 | 50 | 75 |
(+/-) | 0/30 | 0/30 | 30/0 | |
THC | (ng/ml) | 0 | 25 | 75 |
(+/-) | 0/30 | 0/30 | 30/0 |
A drug-free urine pool was spiked with drugs at the listed concentrations. The results are summarised below.
Drug Concentration Cut-off Range |
AMP |
BZO |
COC |
OPI |
MET |
THC |
||||||
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
|
0% Cut-off |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
-50% Cut-off |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
-25% Cut-off |
27 |
3 |
27 |
3 |
26 |
4 |
26 |
4 |
27 |
3 |
26 |
4 |
Cut-off |
15 |
15 |
16 |
14 |
13 |
17 |
15 |
15 |
16 |
14 |
14 |
16 |
+25% Cut-off |
4 |
26 |
3 |
27 |
3 |
27 |
3 |
27 |
3 |
27 |
3 |
27 |
+50% Cut-off |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
+300% Cut-off |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |
0 |
30 |